February 2026
Every article Wellness Radar published in February 2026 — long-form research, protocols, and reference work. Most-recent first.
VO2max protocol — Norwegian 4x4, MAF, and why it matters for longevity
Cooper Institute mortality data on VO2max quintiles (Mandsager 2018), Norwegian 4x4 (Helgerud) vs Zone 2 (Maffetone) evidence, time-to-effect, and how to test or track without a metabolic cart.
Rapamycin for longevity: what the trials actually show in humans
PEARL, RAP-PAC, RAPAMUNE off-label use. What the human trials of rapamycin actually report — immune function, glycemia, side effects — and what the longevity claim still rests on.
Deep Sleep Triggers a Growth Hormone Surge — What the Cell Study Means for Recovery
UC Berkeley researchers published in Cell that deep slow-wave sleep activates a brain circuit controlling pulsatile GH release — and GH itself feeds back to regulate wakefulness. The bidirectional loop that peptide us…
Retatrutide: the triple agonist that could rewrite the GLP-1 era
Retatrutide is a GLP-1/GIP/glucagon triple agonist from Eli Lilly. Phase-2 hit 24.2% weight loss at 48 weeks. What the TRIUMPH phase-3 program must prove next.